Posts Tagged ‘pharmaceutical jobs’

Analytical Development Scientist Role – M4 corridor

Monday, September 5th, 2011

Jason Johal is currently recruiting for a Senior Analytical Chemist to join a global pharmaceutical and biopharmaceutical CMO based along the M4 Corridor and commutable from Oxfordshire.

Responsibilities:

The ideal candidate for this Senior Analytical Chemist role will provide analytical support to the development and manufacture of a wide range of dosage forms from early formulation studies and clinical trial manufacture to NDA registration. This role will be very varied and includes method development and validation, provision of support during formulation development and manufacture, release testing and stability studies.  The nature of the environment is fast paced. As such you would have a number of projects to work on at any one time spanning a diverse product, dosage form and client range. With this in mind good organisational skills are essential.

Qualifications:

The successful candidate for this Senior Analytical Chemist role must be qualified in Chemistry or a related subject (or equivalent) and previous laboratory experience, preferably in pharmaceutical analytical development is required. Proven experience in HPLC method development and validation are essential. Also the ideal candidate will have experience of working to cGLP / GMP and will have used the techniques as described above as well as GC, UV and dissolution techniques.

How to apply:

For more information or to apply for this Senior Analytical Chemist  please contact Jason Johal on 01438 723 500 or jjohal@ckscience.co.uk.   Please quote reference ST22590 in all correspondence.

 

                                                       Click here to apply online now!

QinetiQ Sells Fuel Business to Intertek

Wednesday, August 10th, 2011

The QinetiQ Group, based in Farnborough, is selling off its fuel and lubricants business for £500,000, reports insidermedia.com.

The Intertek Group is to take over the UK Fuel and Lubricants Testing Business (OALTB), which QinetiQ has sold in order to concentrate on their core services, including aerospace and security. Intertek is going to bring the fuel business into the pharmaceutical and chemical division of their operations.

This is the third recent acquisition by Intertek, who have also purchased Stoke based Food Analytical Laboratories Limited (FAL) and Rechere Developpement and Consulting (RDC), based in Brussels. Wolfhart Hauser, CEO of Intertek, has said the purchases “demonstrate Intertek’s progress in its strategy to add new expertise and capabilities across the supply chain.” He later commented that the firm is looking forward “to welcoming these companies and their management teams to Intertek.”

Looking for a job in the science industry? Start by clicking here, now

Benfits Merger Worry For Pharma Companies

Tuesday, July 26th, 2011

Two pharmacy benefits companies are set to merge in a multi-billion dollar deal, reports fiercepharma.com.

Pharmaceutical companies are beginning to worry that due to the proposed $29 billion deal that will see Express Scripts buy Medco Health Solutions, drug prices could decrease, affecting the pharamceutical compnies profits. Most who have commented on the deal, including Eli Lilly’s CFO Dernica Rice, have played down the impact the buy-out will have, with Rice saying Lilly could maintain its negotiation power through their products advantage over the generic drugs on the market.

However, Michael Luby, of BioPharma Alliance, believes the merger will mean the combined company would have “extraordinary purchasing power… [and] leverage [over] pharmaceutical companies.” Price cuts in Europe; particularly Germany and Spain, have been causing pharmaceutical companies problems, and having staved off effort from the US government over pricing, the big companies are now going to have to attempt to stop the private sector submitting the pharmaceutical sector to the same pricing measures.

Looking for a job in the science industry? Start by clicking here, now

Nominate CK Science in the NORA’s 2011!

Friday, July 22nd, 2011

Nominate CK Science for the National Online Recruitment Awards (NORA’s) 2011!

 Nominations are currently being received for the awards, a prestigious honour created to recognise and reward excellence in the recruitment industry.

 This is something we always strive for; we go to great lengths in order to help those in the science industry to find a job, particularly with our website, catered towards the internet savvy candidate of today. We have daily updates of all the latest jobs, industry updates and weekly video content, as well as expanding our presence on social networking sites, meaning that we can have constant communication and feedback from you, the candidate.

 If you believe CK Science deserves to be recognised at the NORA’s; click here or the banner above, it will be greatly appreciated!

GSK to Create 1,000 UK Jobs

Wednesday, July 20th, 2011

GlaxoSmithKline intends to make a £500 million investment into one of four UK sites, reports the Montrose Review.

The investment is expected to create up to 1,000 jobs in one of four UK plants, with Montrose thought to be the front runner due to the recent movement of biomanufacturing of several products from India to the Montrose plant. The Montrose factory also manufactures the products needed to make products that GSK inherited following its acquisition of Steifel in 2009.

Andrew Witty, GSK chief executive, praised the 280 staff at the Montrose factory for turning around what was an ailing site, up for sale at the turn of the Millennium, into a “globally competitive” production plant.

Looking for a job in the science industry? Start by clicking here, now

Biopharmacologist Role (Neuroscience) – Herts

Monday, July 18th, 2011

Jason Johal is currently recruiting for a Biopharmacologist to work within Neuroscience for a Global Pharmaceutical company based in Hertfordshire.

Responsibilities:

As a global Neuroscience Principal Researcher, you will contribute to executing projects and will be expected to design and execute experiments independently and conduct research activities within established guidelines. You will also be expected to participate in discussion and review of new targets.

The role will include but will not be limited to the following activities:-

  • The collection and collation of results and conclusions.
  • Collaborating effectively with fellow project members to accomplish team goals in an efficient manner on time and within budget.
  • Reviewing the effectiveness of current laboratory equipment and suggesting ways to better manage available equipment within research programs.
  • Testing standard procedures to provide recommendations for improvement for use across programs.
  • Contributing to information database development
  • Contributing to the preparation and submission of patents, scientific publications and regulatory documents.

Skills and Qualifications:

The ideal candidate should have recognised expertise in a wide range of in vivo pharmacological techniques and the ability to conduct in vivo studies utilising biochemical and behavioural endpoints is critical. A general scientific background in the field of neurodegenerative disorders is also essential.

How to apply

For more information or to apply for this Biopharmacologist position, please contact Jason Johal on 01438 723 500 or jjohal@ckscience.co.uk.  Please quote reference ST22388 in all correspondence.

                                                         Click here to apply online

Inhalation Analyst – Nottingham

Monday, July 18th, 2011

Hannah Milward is currently seeking to recruit an Inhalation Analyst to work with them at their site in Nottingham on a contract basis to cover an imminent maternity cover.

Responsibilities:

This role will involve carrying out analysis using techniques including Anderson Cascade Impaction and to ensure work is carried out in compliance to GMP. Other duties will include maintenance of equipment, taking part in internal and external QA assessments and completing paperwork amongst others.

Qualifications:

Candidates should be educated to degree level, or equivalent, in a relevant scientific subject and have experience of analysis of inhalation formulations.

Apply now:

For more information or to apply for this Inhalation Analyst position, please contact Hannah Milward on 0114 2839956 or hmilward@ckscience.co.uk.  Please quote reference SH22370 in all correspondence.

                                                        Click here to apply now!

Promising Scientists to Receive Grant

Friday, July 15th, 2011

Cancer Research UK is making an investment into clinical research, reports cslrecruitment.com.

A £12 million grant is to be made to ten promising researchers who are expected to become prominent in the field of cancer. It is intended to assist with the researcher’s careers and possible breakthroughs they could make. Two leading university lecturers, four scientists and four junior research scientists will be the recipients of the grant.

Applicants are being taken, with the deadline at the end of July drawing closer. Dr David Scott, director of science funding at Cancer Research UK, believes the grants show his organisation “is serious about supporting new scientists at the start of their careers.”

Looking for a job in the science industry? Start by clicking here, now

Bid Could Create Thousands of Jobs in Runcorn

Thursday, July 14th, 2011

A science park in Runcorn is bidding to win Enterprise status and create thousands of jobs, reports runcornandwidnesworld.co.uk.

If the Daresbury Science and Innovation Park is granted this status, then it could generate up to 10,000 skilled jobs and lead to £150 million investment. Holton Council leader Clr Rob Polhill has said the status would “take Daresbury to the next level.”

Around 100 companies have offices, workshops and laboratories on the site, and the massive investment would mean that even more specialist office, lab and technical spaces would be developed. The site opened in 2006 and is a world class centre for cutting edge sciences and high-tech businesses.

Looking for a job in the science industry? Start by clicking here, now

Pfizer Separate Divisions to Allow Growth

Friday, July 8th, 2011

Pharmaceutical company Pfizer’s decision to separate certain divisions could lead to a larger break up in order for further growth, including in employment, reports forbes.com.

The splitting of the animal health and baby formula businesses from the main company is the beginning of a process to unlock value within the company. Two other sectors will be kept in order to raise their value to $46 billion combined, though investors had hoped the company would split into five distinct divisions.

The two that have broken off were the obvious choices; the animal health business is worth nearly $4 billion so can stand on its own, and the nutrition side is the one that investors were most eager to see separate.

Though some investors may be disappointed that Pfizer hasn’t split all its divisions at once, it means that sectors that could not currently compete on their own have time to grow to the point where they can be world leaders in their own right, potentially creating a large number of jobs worldwide.

Looking for a job in science? Start by clicking here, now

Search for a job

Advanced search

20 years Download the CK Science iPhone App

Subscribe to our newsletter

Preview
Powered by FeedBlitz